Usana Health Sciences Inc. Stock Upgraded (USNA)
- Despite its growing revenue, the company underperformed as compared with the industry average of 7.1%. Since the same quarter one year prior, revenues slightly increased by 6.3%. This growth in revenue appears to have trickled down to the company's bottom line, improving the earnings per share.
- USNA has no debt to speak of therefore resulting in a debt-to-equity ratio of zero, which we consider to be a relatively favorable sign.
- The gross profit margin for USANA HEALTH SCIENCES INC is currently very high, coming in at 82.40%. It has increased from the same quarter the previous year. Along with this, the net profit margin of 8.60% is above that of the industry average.
- USANA HEALTH SCIENCES INC's earnings per share improvement from the most recent quarter was slightly positive. The company has demonstrated a pattern of positive earnings per share growth over the past two years. We feel that this trend should continue. During the past fiscal year, USANA HEALTH SCIENCES INC increased its bottom line by earning $2.85 versus $2.17 in the prior year. This year, the market expects an improvement in earnings ($3.23 versus $2.85).
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.